India Makes Major Strides Towards TB Elimination: 38% Decline in TB Mortality, 94% Treatment Success Rate

1. At a Glance

• WHO Global Tuberculosis Report 2026 finds that India's estimated TB deaths fell 38% since 2015. The global fall over the same period was 35%, so India did better than the world average [1].
• Treatment success rate for drug-susceptible TB has reached 94%. Credit goes to the National TB Elimination Programme (NTEP) and the TB Mukt Bharat Abhiyaan [1].
• The model combines active case finding, AI-enabled chest X-ray + NAAT diagnosis, nutritional support (Ni-kshay Poshan Yojana / Ni-kshay Mitra) and Jan Bhagidari (people's participation) [1].
• UPSC relevance: health governance (GS-II), S&T (GS-III), SDG 3.3 (end the TB epidemic by 2030) [5], and a model of domestic financing (96% of programme funding is domestic) [1].

2. Why in the News

• 12 November 2026: WHO released the Global TB Report 2026. It records India's 38% mortality decline and 94% treatment success [1].
• The TB death rate fell from 28 per lakh (2015) to 18 per lakh (2025) [1].
• 24 March 2026: the second 100-day TB Mukt Bharat Abhiyaan was launched [1].
• From 7 December 2024 to 8 November 2026, over 25 crore people were screened, and 48.64 lakh new cases were found. 14.97 lakh of these had no symptoms [1].

3. Background & Evolution

• Global framework: the WHO End TB Strategy runs from 2016 to 2035, with 2015 as the baseline [5][6].
• 9 September 2022: President Droupadi Murmu virtually launched the Pradhan Mantri TB Mukt Bharat Abhiyaan as a component of NTEP. It aims to give TB patients extra support and to increase community involvement. The Ni-kshay Mitra platform for adopting patients was part of it [2].
• 7 December 2024: the first 100-day intensified campaign began in 347 districts. Its strategies were later expanded to all districts nationwide [3][1].
• 24 March 2026: the second 100-day campaign was launched [1].
• 12 November 2025: WHO's 2025 report warned that global TB gains were "endangered by funding challenges". TB still killed over 1.2 million people and affected about 10.7 million worldwide [4].
• 12 November 2026: the WHO 2026 report recorded India's 38% mortality decline [1].

4. Core Static Facts

5. Multi-Dimensional Analysis

Scientific / Technological

• AI-enabled chest X-rays plus NAAT found 14.97 lakh people with TB but no symptoms. Without screening, they would have gone undiagnosed and kept spreading the disease [1].
• AI tools flag high-risk patients who are likely to have poor outcomes. Their care is then adjusted to their risk (differentiated care) [1].
• The mortality estimate is stronger because it combines SRS, verbal autopsy and Ni-kshay data, not programme data alone [1].

Social

• Nutrition is treated as a pillar of TB care. Undernutrition is a comorbidity, and Ni-kshay Poshan Yojana and Ni-kshay Mitra target it directly [1][2].
• TB screening is combined with checks for diabetes and undernutrition, which makes care patient-centred [1].
• Ni-kshay Mitras also provide psychosocial and vocational support, which helps patients stay on treatment and reduces stigma [1][2].

Economic

• 96% domestic funding protects India from shrinking donor money, which WHO flagged as a global risk in 2025 [1][4].
• The End TB target of zero catastrophic costs for affected families links TB control to financial protection against health costs [5].

Governance / Administrative

• Jan Bhagidari: PRIs, urban local bodies, private providers, corporates and youth (JOSH Teams) push the programme down to the grassroots [1].
• The Ni-kshay portal supports real-time monitoring and accountability [1].
• The campaign was piloted in 347 districts and then scaled up nationwide, a phased implementation model [3].

Geopolitical / Global health

• India beat the global average for mortality decline (38% vs 35%) [1]. This strengthens its standing in global health (South–South cooperation, Global South leadership).

6. Recent Developments (last 12–18 months)

• 12 November 2025: WHO Global TB Report 2025 put global TB deaths at 1.2 million+ and cases at 10.7 million, with funding risks highlighted [4].
• March 2026: 6,77,541 Ni-kshay Mitras enrolled, 45 lakh+ food baskets distributed, and 2 lakh+ MY Bharat volunteers had come forward as Ni-kshay Mitras [3].
• 24 March 2026 (World TB Day): the second 100-day TB Mukt Bharat Abhiyaan was launched [1].
• 8 November 2026: cumulative screening passed 25 crore people [1].
• 12 November 2026: WHO Global TB Report 2026 recorded the 38% mortality decline and 94% treatment success [1].

7. Prelims Hooks

• India's TB deaths fell 38% since 2015, against a global fall of 35% (WHO Global TB Report 2026) [1].
• India's TB death rate: 28 per lakh (2015) → 18 per lakh (2025) [1].
• 94% treatment success rate applies to drug-susceptible TB, not drug-resistant TB [1].
• 96% of India's TB programme funding is domestic [1].
• The first 100-day TB Mukt Bharat Abhiyaan began on 7 December 2024 in 347 districts [1][3].
• The second 100-day campaign began on 24 March 2026 [1].
• The Pradhan Mantri TB Mukt Bharat Abhiyaan was launched on 9 September 2022 by President Droupadi Murmu [2].
• Ni-kshay Mitra lets individuals, companies, NGOs and co-operatives adopt TB patients [2].
• JOSH Teams: 1 Class-I officer + 5 NCC cadets + 5 MY Bharat volunteers [1].
• NAAT is a molecular test that detects TB genetic material [1].
• Inputs to WHO's estimate of India's TB deaths: RGI–SRS, community verbal autopsy, Ni-kshay data [1].
• 14.97 lakh asymptomatic cases among 48.64 lakh new cases (7 December 2024 to 8 November 2026) [1].
• End TB Strategy 2030 targets: 80% lower incidence and 90% fewer deaths vs 2015 [5].
• SDG indicator 3.3.2 = TB incidence per 1,00,000 population [5].
• TB elimination as a public health problem = <1 case per million population [5].

8. Fewer Deaths Does Not Mean Less TB Spreading

• Deaths and new cases are two different numbers. Cases are falling much more slowly.
• TB incidence (the number of new TB cases each year, per 1,00,000 people) fell from 237 per lakh in 2015 to 187 per lakh in 2024. That is a fall of about 21% [7].
• Deaths fell 38% over a similar period [1].

• Why the gap? Better diagnosis and treatment save the people who already have TB. But they do not stop new people from getting infected as quickly.

• The 2030 target needs India to move about four times faster on new cases

• The End TB Strategy wants 80% fewer new cases by 2030, compared with 2015 [5]. For India, that means about 47 per lakh.
• Between 2015 and 2024, India's rate fell by about 5–6 points a year (237 → 187) [7].

• To get from 187 to about 47 by 2030, it must fall by about 23 points a year. That is roughly four times the past speed (my rough calculation from [5] and [7] figures).

• The death target is also far away

• The 2030 target is 90% fewer deaths than in 2015 [5]. India is at 38% [1].

• Using the rate figures, a 90% fall from 28 per lakh means about 3 per lakh. India is at 18 per lakh [1]. (This is a rough guide: WHO counts the target in total deaths, not rates.)

• "Elimination" is a much higher bar than "control"

• Elimination means fewer than 1 case per million people, which is 0.1 per lakh [5].
• India's rate of 187 per lakh [7] is about 1,870 times that level (my calculation).
• So in an answer, call the 38% figure progress towards control, not "near elimination".

9. Why Finding More Cases Is Good News, Not Bad

• Active screening pushes the reported case count up, even while TB itself goes down
• The 100-day campaigns screened over 25 crore people and found 48.64 lakh new cases [1].
• About 14.97 lakh of them, nearly a third, had no symptoms [1]. Under the old system, these people would never have walked into a clinic, so they would never have been counted.

• A newspaper headline saying "record TB cases reported" can therefore be a sign of better searching, not more disease.

• How to tell the two apart: look at treatment coverage, not notifications

• Notifications are the cases reported to the government. Treatment coverage is the share of all estimated TB patients who are actually found and treated.
• India's treatment coverage rose from 53% in 2015 to 92% in 2024 [7].
• So the "missing" patients (estimated by WHO but never reported) have fallen from almost half to under one in ten (my calculation from [7]).

• This matters because an undiagnosed patient keeps infecting others. Finding them early is how incidence will eventually fall.

• How to read next year's report

• Judge India by incidence and deaths (WHO estimates [1][7]), not by the raw number of notified cases.
• Rising notifications together with falling incidence is the pattern that shows the strategy is working.

10. What the 94% Success Rate Does Not Count

• The 94% is measured only on patients who were found and started on treatment
• Treatment success is worked out only for patients who are registered on treatment.
• Treatment coverage was 92% in 2024 [7]. So roughly 8% of estimated patients were not on treatment and are not part of the 94% at all (my calculation).

• In plain terms: 94% of the patients India treats get cured. That is not the same as 94% of all TB patients in India getting cured.

• Drug-resistant TB is a separate, harder number

• The 94% applies only to drug-susceptible TB (TB that the standard medicines can still kill) [1].

• Drug-resistant TB needs longer and more toxic treatment, and it is reported separately. Check its success rate in the WHO country profile before using 94% in an answer.

• The third End TB target is missing from the headline

• The End TB Strategy has three targets: fewer cases, fewer deaths, and 0% of TB-affected families facing catastrophic costs [5].
• "Catastrophic costs" means a family spends so much on TB (treatment, travel, lost wages) that it falls into financial crisis.
• The government summary of the 2026 report gives figures for deaths and treatment success, but none for catastrophic costs [1].
• This matters because a family that is pushed into debt may stop treatment early. The nutrition support schemes exist to prevent exactly this [1][2], yet their effect on family costs is not reported alongside the headline.

11. What Should Come Next, and Who Should Do It

• NTEP should make AI chest X-ray screening a routine, year-round service, not just a campaign
• Nearly a third of the cases found had no symptoms [1]. Asking people about cough or fever would have missed them.
• Screening in two 100-day bursts finds people, but infection keeps spreading between campaigns.

• The incidence target needs a fall about four times faster than before (see above, from [5][7]). Only continuous early detection can cut the spread that much.

• MoHFW should publish catastrophic-cost data each year, next to deaths and success rates

• The End TB Strategy treats zero catastrophic costs as a core target [5].

• Reporting it with the headline numbers would show whether Ni-kshay Poshan Yojana and Ni-kshay Mitra support [1][2] are actually protecting families from financial crisis.

• The government should report incidence as the main success measure

• Deaths can fall through better treatment alone. Incidence falls only when transmission (TB passing from person to person) stops.

• SDG 3.3 itself is measured by incidence (indicator 3.3.2), not deaths [5]. India's progress reports should lead with that number.

• Keep financing domestic, but plan for higher costs as the programme widens

• India already pays for 96% of its programme from its own resources [1]. Global donor money is shrinking [4].
• Year-round AI screening, molecular tests (NAAT) and nutrition support for every patient will cost more than campaign-based screening. Health budgets need to plan for this, because outside donors will not fill the gap.

12. Anchors for Answers

• Data: TB incidence 237 → 187 per lakh (2015–2024), a fall of about 21%. Deaths fell faster, by 38% [7][1]
• Data: Treatment coverage rose from 53% (2015) to 92% (2024), so far fewer patients are "missing" [7]
• Data: 14.97 lakh of 48.64 lakh new cases had no symptoms. Symptom-based screening would have missed them [1]
• Report/Committee: WHO Global Tuberculosis Report 2025 and 2026; WHO End TB Strategy (2016–2035) [5][7][1]
• Comparison: End TB 2030 targets (80% fewer cases, 90% fewer deaths, 0% catastrophic costs) vs India's 21% and 38% [5][7][1]
• Scheme: Ni-kshay Poshan Yojana and Ni-kshay Mitra, the tools meant to stop TB from pushing families into catastrophic costs [1][2]

13. Mains Relevance

• GS-II: Issues relating to development and management of social sector/services relating to Health; government policies and interventions; role of NGOs, SHGs and community participation.
• GS-III: Science & Technology, applications in everyday life (AI diagnostics, molecular testing).
• GS-IV (peripheral): community responsibility and compassion (the Ni-kshay Mitra model).
• Question stems: 1. India's decline in TB mortality has outpaced the global average. Examine the role of active case finding and technology in this outcome, and identify the remaining gaps in achieving the End TB targets. (15 marks) 2. Nutrition is increasingly seen as a pillar of TB control. Discuss in the context of the Ni-kshay Poshan Yojana and Ni-kshay Mitra initiatives. (10 marks) 3. Jan Bhagidari can turn a disease-control programme into a people's movement. Critically analyse with reference to the TB Mukt Bharat Abhiyaan. (15 marks)

14. Related Topics to Study Next

• WHO End TB Strategy and SDG 3.3: the global targets India is measured against.
• Drug-resistant TB (MDR/XDR) and shorter regimens: the 94% success figure does not cover drug-resistant TB.
• Sample Registration System (RGI): how mortality data is produced in India.
• Ayushman Bharat – Health and Wellness Centres / Ayushman Arogya Mandirs: the primary-care platform for screening.
• POSHAN Abhiyaan / undernutrition: the link between undernutrition and TB.
• AI in healthcare (IndiaAI Mission, ICMR initiatives): diagnostic technology in public health.
• MY Bharat platform and NCC: the youth-mobilisation channels behind JOSH Teams.
• Global Fund / funding of global health: context for WHO's 2025 funding warning [4].

15. NCERT Concepts to Revise

• Sustainable Development Goal 3 (Economy): SDG 3.3 targets ending the TB epidemic by 2030, the benchmark India's progress is measured against.
• World Health Organization (Polity): WHO publishes the Global TB Report and the End TB Strategy that set India's targets.
• Sample Registration System (Geography): SRS data is one input to WHO's estimate of India's TB deaths.
• Registrar General of India (Polity): The RGI runs the SRS, which supplies the mortality data behind the 38% figure.
• Mortality rate (Economy): The article's headline is a fall in TB death rate from 28 to 18 per lakh.
• Ayushman Arogya Mandir (Economy): These primary-care centres are the platform for community TB screening.
• Artificial intelligence (Economy): AI-enabled chest X-rays found nearly 15 lakh TB cases that had no symptoms.
• IndiaAI Mission (Economy): National AI programme behind the diagnostic technology used in public health, such as TB screening.
• POSHAN Abhiyaan (Economy): Undernutrition drives TB, so this national nutrition mission links to Ni-kshay Poshan support.
• Community participation (Economy): Jan Bhagidari and Ni-kshay Mitra rely on citizens, firms and NGOs joining the TB effort.
• Urban local bodies (Polity): Urban local bodies are among the grassroots institutions the note names for pushing the programme down to the ground.
• Screening (Economy): Active screening raises reported case counts even while TB itself declines, so reading notifications correctly matters.
• Global South (Polity): India's faster mortality decline than the world average strengthens its leadership claim among developing countries.

16. Common Errors / Trap Areas

• Two different "Abhiyaans": the PM TB Mukt Bharat Abhiyaan (September 2022) is the community-support and Ni-kshay Mitra initiative [2]. The 100-day TB Mukt Bharat Abhiyaan (December 2024 and March 2026) is the intensified screening campaign [1].
• 94% vs 38%: 94% is treatment success in drug-susceptible TB; 38% is the fall in estimated deaths since 2015 [1]. Neither number refers to incidence.
• The rate figures don't give exactly 38%: going from 28 to 18 per lakh is about a 36% fall. The headline 38% is WHO's estimated mortality decline, so don't try to derive one from the other (my calculation from [1] figures).
• Ni-kshay Poshan Yojana vs Ni-kshay Mitra: the first is government cash support for nutrition; the second is community or corporate adoption of patients [1][2].
• India's own target year vs SDG 2030: India's national TB elimination target is widely reported as 2025, five years ahead of the SDG. I could not verify this in a whitelisted source during this search. The SDG/End TB 2030 targets are cited at [5].